Overview

SCIENTIFIC SCORE
Possibly Effective
Based on 10 Researches
7.9
USERS' SCORE
Good
Based on 2 Reviews
8.4
Supplement Facts
Serving Size: 1 Veg Capsule
Amount Per Serving
%DV
Choline (from 630 mg Choline Bitartrate)
250 mg
45%
Inositol
250 mg
📅 Last updated:

Top Medical Research Studies

We aimed to evaluate how myo-inositol supplementation affects women with gestational diabetes through a meta-analysis of randomized controlled trials. Our search included multiple databases, leading to the analysis of four studies involving 317 participants. The results showed that myo-inositol significantly reduced the need for insulin and improved insulin sensitivity. However, it did not influence birth weight, cesarean delivery rates, or NICU admissions. These findings suggest myo-inositol could be a helpful addition to managing gestational diabetes, but further research is needed.
Read More
9.5
Inositol reduces gestational diabetes risk
We investigated the effectiveness of myoinositol supplements in preventing gestational diabetes mellitus (GDM) and its associated complications in pregnant women at high risk for GDM.

By reviewing data from eight randomized controlled trials involving around 1,795 participants, we found that inositol not only halved the incidence of GDM but also significantly reduced fasting and glucose levels in tests.

Furthermore, myoinositol appeared to lower the need for insulin and decrease the risk of conditions like preeclampsia and preterm birth. These findings suggest a promising role for myoinositol in GDM prevention.
Read More
8
Myo-inositol improves glycemic control
This study explored the impact of myo-inositol (MI) supplementation on preventing gestational diabetes mellitus (GDM) in 200 pregnant women. Participants were divided into two groups: one receiving MI and folic acid, and the other receiving only folic acid.

The findings revealed that those taking MI had a significantly lower incidence of GDM compared to the control group. Additionally, those in the MI group showed better glycemic control and improved insulin sensitivity. Overall, integrating MI might offer an effective way to enhance the health of pregnant women and reduce GDM risk.
Read More

Most Useful Reviews

9
Improved glucose levels
1 people found this helpful
Since taking Now's inositol, my glycated haemoglobin levels have significantly improved over time. Each check-up reveals lower glycated levels, which is wonderful news for my diabetes management. The brand's quality is outstanding.
Read More
7.5
Lost 50 points
54 people found this helpful
I have Type 2 diabetes and, using bulk supplements including Pure Grape Seed and Pine Bark Extract, I've lost an average of 50 points in my morning readings. Research is key; don't blindly trust your doctor's prescriptions.
Read More

Most Recommended Products for Diabetes

NOW Foods Zinc Glycinate
SCIENTIFIC SCORE
Likely Very Effective
Based on 2 Researches
9
USERS' SCORE
Good
Based on 3 Reviews
8.4
Doctor's Best Nattokinase
SCIENTIFIC SCORE
Moderately Effective
Based on 4 Researches
8.5
USERS' SCORE
Good
Based on 11 Reviews
8
Solgar Taurine
SCIENTIFIC SCORE
Moderately Effective
Based on 21 Researches
8.1
USERS' SCORE
Good
Based on 3 Reviews
8.3
Natrol Omega-3 Fish Oil
SCIENTIFIC SCORE
Possibly Effective
Based on 16 Researches
7.9
USERS' SCORE
Good
Based on 6 Reviews
8.5

Medical Researches

SCIENTIFIC SCORE
Possibly Effective
Based on 10 Researches
7.9
  • All Researches
9.5
Inositol reduces gestational diabetes risk
We investigated the effectiveness of myoinositol supplements in preventing gestational diabetes mellitus (GDM) and its associated complications in pregnant women at high risk for GDM.

By reviewing data from eight randomized controlled trials involving around 1,795 participants, we found that inositol not only halved the incidence of GDM but also significantly reduced fasting and glucose levels in tests.

Furthermore, myoinositol appeared to lower the need for insulin and decrease the risk of conditions like preeclampsia and preterm birth. These findings suggest a promising role for myoinositol in GDM prevention.
Read More
9
New drug shows promise for diabetes
We evaluated the effectiveness of Xelaglifam, a new drug designed to activate specific receptors that help manage Type 2 diabetes. Our study compared its performance against another drug, Fasiglifam.

Through tests in the lab and on rats, we found that Xelaglifam boosts insulin secretion and lowers blood sugar levels effectively without causing hypoglycemia.

Additionally, its ability to improve glucose tolerance suggests it could be a valuable treatment option for those managing this condition, potentially working well alongside existing medications.
Read More
8
D-Pinitol and ice plant benefits
We explored the effects of ice plant extract and its compound D-pinitol on insulin secretion and blood sugar levels in diabetic rats. By utilizing the glucose-stimulated insulin secretion test and measuring various insulin-related factors, we discovered that both substances significantly boosted insulin secretion.

Additionally, ice plant extract helped reduce weight gain and improved glucose tolerance. These findings suggest that ice plant and D-pinitol could serve as beneficial functional foods for managing diabetes and supporting insulin signaling in the body.
Read More
8
Histatin 1 enhances diabetic wound healing
We explored how Histatin 1, found in human saliva, helps combat aging in human umbilical vein endothelial cells (HUVECs) to improve diabetic wound healing. The study revealed that this peptide reduces cell senescence and works by enhancing mitochondrial function and reducing oxidative stress.

In laboratory settings, Histatin 1 decreased markers of aging in cells and improved their function. Furthermore, in a mouse model of diabetes, it promoted wound healing through increased blood vessel formation.

Overall, Histatin 1 shows promise as a solution for improving skin repair in diabetic patients.
Read More
8
Myo-inositol improves glycemic control
This study explored the impact of myo-inositol (MI) supplementation on preventing gestational diabetes mellitus (GDM) in 200 pregnant women. Participants were divided into two groups: one receiving MI and folic acid, and the other receiving only folic acid.

The findings revealed that those taking MI had a significantly lower incidence of GDM compared to the control group. Additionally, those in the MI group showed better glycemic control and improved insulin sensitivity. Overall, integrating MI might offer an effective way to enhance the health of pregnant women and reduce GDM risk.
Read More

User Reviews

USERS' SCORE
Good
Based on 2 Reviews
8.4
  • All Reviews
  • Positive Reviews
  • Negative Reviews
9
Improved glucose levels
1 people found this helpful
Since taking Now's inositol, my glycated haemoglobin levels have significantly improved over time. Each check-up reveals lower glycated levels, which is wonderful news for my diabetes management. The brand's quality is outstanding.
Read More
7.5
Lost 50 points
54 people found this helpful
I have Type 2 diabetes and, using bulk supplements including Pure Grape Seed and Pine Bark Extract, I've lost an average of 50 points in my morning readings. Research is key; don't blindly trust your doctor's prescriptions.
Read More

Frequently Asked Questions

9
Improved glucose levels
1 people found this helpful
Since taking Now's inositol, my glycated haemoglobin levels have significantly improved over time. Each check-up reveals lower glycated levels, which is wonderful news for my diabetes management. The brand's quality is outstanding.
8
Myo-inositol improves glycemic control
This study explored the impact of myo-inositol (MI) supplementation on preventing gestational diabetes mellitus (GDM) in 200 pregnant women. Participants were divided into two groups: one receiving MI and folic acid, and the other receiving only folic acid.

The findings revealed that those taking MI had a significantly lower incidence of GDM compared to the control group. Additionally, those in the MI group showed better glycemic control and improved insulin sensitivity. Overall, integrating MI might offer an effective way to enhance the health of pregnant women and reduce GDM risk.
We aimed to evaluate how myo-inositol supplementation affects women with gestational diabetes through a meta-analysis of randomized controlled trials. Our search included multiple databases, leading to the analysis of four studies involving 317 participants. The results showed that myo-inositol significantly reduced the need for insulin and improved insulin sensitivity. However, it did not influence birth weight, cesarean delivery rates, or NICU admissions. These findings suggest myo-inositol could be a helpful addition to managing gestational diabetes, but further research is needed.
8
Myo-inositol aids diabetic management
We explored the effects of myo-inositol (MI) on diabetes using db/db mice, a common model for type 2 diabetes. Our findings showed that MI successfully lowered high blood glucose and insulin levels while improving insulin resistance, performing similarly to metformin.

Additionally, MI reduced triglycerides and cholesterol, demonstrating its potential benefits for metabolic health. Although it inhibited the formation of fat cells from stem cells, MI did not address obesity in these mice. Overall, our study suggests that MI may be a valuable supplemental treatment for managing diabetes-associated conditions.

References

  1. Lee D, Kim SJ, Choi YJ, Rho YH, Kang TS, et al. The Glucose-Lowering Effect of and D-Pinitol: Studies on Insulin Secretion in INS-1 Cells and the Reduction of Blood Glucose in Diabetic Rats. Nutrients. 2025;17. 10.3390/nu17010193
  2. Xian T, Liu Y, Ye Y, Peng B, Huang J, et al. Human salivary histatin 1 regulating IP3R1/GRP75/VDAC1 mediated mitochondrial-associated endoplasmic reticulum membranes (MAMs) inhibits cell senescence for diabetic wound repair. Free Radic Biol Med. 2024;225:164. 10.1016/j.freeradbiomed.2024.09.046
  3. Asimakopoulos G, Pergialiotis V, Antsaklis P, Theodora M, Loutradis D, et al. Effect of dietary myo-inositol supplementation on the insulin resistance and the prevention of gestational diabetes mellitus: an open-label, randomized controlled trial. Arch Gynecol Obstet. 2024;310:1895. 10.1007/s00404-024-07618-8
  4. Chen H, Xiong J, Li Z, Chen Y, Zhang M, et al. Influence of myo-inositol on metabolic status for gestational diabetes: a meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med. 2024;37:2228450. 10.1080/14767058.2023.2228450
  5. Yoon J, Lee DG, Song H, Hong D, Park JS, et al. Xelaglifam, a novel GPR40/FFAR1 agonist, exhibits enhanced β-arrestin recruitment and sustained glycemic control for type 2 diabetes. Biomed Pharmacother. 2024;177:117044. 10.1016/j.biopha.2024.117044
  6. Long L, Huang Q, Song T, Dai Z. Myo-inositol rescued insulin resistance and dyslipidemia in db/db mice. J Appl Biomed. 2024;22:74. 10.32725/jab.2024.009
  7. Aguilar-Guadarrama AB, Díaz-Román MA, Osorio-García M, Déciga-Campos M, Rios MY. Chemical Constituents from Agave applanata and Its Antihyperglycemic, Anti-inflammatory, and Antimicrobial Activities Associated with Its Tissue Repair Capability. Planta Med. 2024;90:397. 10.1055/a-2270-5527
  8. Citarrella R, Chianetta R, Amodeo S, Mirarchi L, Licata A, et al. Effectiveness of a Food Supplement Based on Glucomannan, D-Chiro-Inositol, Blume and Inulin in Patients with Metabolic Syndrome. Nutrients. 2024;16. 10.3390/nu16020249
  9. Factor PA, Corpuz H. The Efficacy and Safety of Myo-inositol Supplementation for the Prevention of Gestational Diabetes Mellitus in Overweight and Obese Pregnant Women: A Systematic Review and Meta-Analysis. J ASEAN Fed Endocr Soc. 2023;38:102. 10.15605/jafes.038.02.11
  10. Greff D, Váncsa S, Váradi A, Szinte J, Park S, et al. Myoinositols Prevent Gestational Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2023;15. 10.3390/nu15194224
image